Literature DB >> 26364460

Synchronous gastric and colonic cancer--A case report.

Trifunović Bratislav, Nešković Branimir, Bezmarević Mihailo, Kršić Jovan, Milić Veljović, Zeljković Dejan.   

Abstract

INTRODUCTION: Synchronous gastric and colorectal cancer is present in 4% of cases, commonly as additional finding. This is the case of invasive, synchronous gastric and sigmoid colon cancer. CASE REPORT: A 63-years-old male patient admitted to our institution complaining on pains in epigastrium, vomiting, rapid weight loss and occasional constipation. Using the method of esophagogastroduodenoscopy (EGD) the presence of ulcero-infiltrative tumor of gastric fundus was verified, and colonoscopy revealed stenosing tumor of sigmoid colon. Undergoing a multislice computed tomography (MSCI) of the thorax and the abdomen the changes on the patient's right lung appeared, while video-assisted thoracoscopy (VATS) and biopsy of the right lung excluded malignant dissemination. A total gastrectomy with omentectomy, splenectomy, D2 lymphadenectomy and typical left hemicolectomy were also performed. Histopathological examination verified invasive, diffuse gastric adenocarcinoma and invasive, tubular colon adenocarcinoma. The patient underwent systemic postoperative chemotherapy. Two years after the surgical procedure, the patient is alive, with no signs of recidivism.
CONCLUSION: In patients with symptomatology which does not correspond to primary malignancy, just like in the presented case, additional diagnostics is required. Combined resection is adequate surgical procedure for synchronous gastric and colonic cancer.

Entities:  

Mesh:

Year:  2015        PMID: 26364460

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  1 in total

1.  Synchronous multiple primary gallbladder and gastric malignancies: Report of two cases and review of the literature.

Authors:  Shuo Zhou; Zheng Lu; Hua Wu; Cong-You Gu; Deng-Yong Zhang; Wan-Liang Sun; Xiang Ma; Hui-Chun Liu
Journal:  Mol Clin Oncol       Date:  2017-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.